Author

Michelle Y. Wang

NYU Langone HealthORCID 0000-0002-7294-0339Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Michelle Y. Wang1 paper

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Akiko KoideiD· 1 shared Alexis D. CorradoiD· 1 shared Christopher Y. ParkiD· 1 shared Dimitris G. PlacantonakisiD· 1 shared Hayley Donaldson· 1 shared Injin BangiD· 1 shared Iryna Berezniuk· 1 shared Karenna J. GroffiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Akiko KoideORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineering Antibody-Drug Conjugates targeting an Adhesion GPCR, CD97

Takamitsu Hattori, Michelle Y. Wang, Alexis D. Corrado, Suzanne Gross, Michelle Fang, Injin Bang, Nainita Roy, Iryna Berezniuk, Hayley Donaldson, Karenna J. Groff, Niklas Ravn-Boess, Akiko Koide, Dimitris G. Placantonakis, Christopher Y. Park, Shohei Koide

This study develops antibody-drug conjugates targeting CD97, an aGPCR overexpressed in cancer, showing efficacy against AML and GBM cells with minimal off-target toxicity.

Proceedings of the National Academy of Sciences · Sep 30, 2025Peer-reviewedBiochemistry